“While further research is required on the biological and clinical aspects of the benefits of cannabis use for HCV [hepatitis C] treatment, and the effectiveness of cannabis use for HCV treatment needs to be explored in larger study populations, we advocate that in the interim existing barriers to cannabis use are removed for drug users undergoing HCV treatment until the conclusive empirical basis for evidence-based guidance is available.”